Raspberry Scientific Inc.

For a Lyme disease screening test you can trust

About Lyme Disease

Patients with Lyme disease  are found in over 80 countries and the number of new infections is growing 25% annually. In the US, the Center for Disease Control (CDC) estimates that 478 000 Americans were infected in 2020. In Canda, there was 2.7 cases per 100,000 population in 2016.

A challenging Diagnosis

It seems more than 50% of the patients tested for Lyme disease generated a false negative result. A potential cause for such results could be the lack of consideration for the multiple co-infections (50+) related to the current diagnostic tests for LD. Indeed, these tests only frame the bacteria Borrelia burgdorferi, which seems to become undetectable a few weeks after the initial infection.

What we develop


Point of care analysis

True Diagnosis

Reduce risks of false negatives

Fast Results

Résultats en 75 minutes

An unrivaled diagnostic tool

Raspberry Scientific develops a multiplex serological test detecting Borrelia burgdorferi, along with more than 25 known co-infections of Lyme disease. This assay is based on our revolutionary technology aiming at analyzing the full spectrum of a patient’s immune response, at point of care, within 75 minutes.

Learn more about Lyme